catalyst

An Extension Study to a Clinical Study That Will Continue to Evaluate the Effect — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2024-09-23 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
An Extension Study to a Clinical Study That Will Continue to Evaluate the Effect — primary completion
Type
Trial Readout
Date
2024-09-23
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication
trial